Screener

Gain Loss On Sale Of Other Assets

Name: Acadia Pharmaceuticals Gain Loss On Sale Of Other Assets by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Acadia Pharmaceuticals·Business Segments·1 segment·Rolls up to Gain Loss On Sale Of Other Assets

Breakdown

Segment	FY'24	FY'25
Business Segments	$146.52M	$0
Total	$146.52M	$0

All segment values are derived from annual filings.

Segments

Business SegmentsView metric